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Abstract
Research participant remuneration has been variable andBackground: 
inconsistent world-wide for many years owing to uncertainty regarding best
practice and a lack of written guidelines for investigators and research ethics
committees.  Recent recommendations are that researchers and regulators
should develop regionally appropriate written guidelines to define reasonable
remuneration based on expense reimbursement, compensation for time and
burden associated with participation.   Incentives to motivate participation are
acceptable in specific circumstances.
We wished to develop regionally informed, precise and applicableMethods: 
guidelines in Malawi that might also be generally useful for African researchers
and review committees.  We therefore reviewed the current literature and
developed widely applicable and specific remuneration tables using acceptable
and evidence-based payment rationales.
There were good international guidelines and limited publishedResults: 
regional guidelines.  There were published examples of best practice and
sufficient material to suggest a structured remuneration table.  The rationale
and method for the table were discussed at an inter-disciplinary workshop
resulting in a reimbursement and compensation model with fixed rates. 
Payment is recommended pro rata and equally across a study.
Transparent, fair remuneration of research participants isConclusions: 
recommended by researchers and regulators in Malawi.  The means to achieve
this are now presented in the Malawi research participant remuneration table.
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Introduction
Remuneration of participants in research by researchers is 
accepted practice1. Further, the lack of any remuneration, 
particularly when research is conducted among vulnerable 
populations, is considered potentially exploitative and hence 
unethical2. Regarding payments, clear statements from the 
Council for International Organisations of Medical Sciences 
(CIOMS)3 as well as country-specific regulators such as 
the Office for Human Research Protection (OHRP) and the 
Federal Drug Administration (FDA) of the USA describe a code 
of practice where remuneration should not be sufficiently large 
to cause “coercion” or “undue influence” of participants1,4. 
Discussion of the means to determine appropriate remuneration 
in Africa without undue influence is the subject of this paper. 
There are currently no specific regional guidelines for Malawi.
Methods
Literature review
To inform this discussion, we carried out a broad literature 
review. Using the search terms “(volunteer or participant or 
patient) AND (remuneration or reimbursement or payment) 
AND (research)”, restricted to English published work in the 
period 1934–2018, we searched MEDLINE Complete, CINAHL 
Complete, Global Health and EBSCO host e-book collection. We 
found 24,605 hits and using the Relevance key, screened titles 
and brief summaries of the most relevant 200 hits. Then, we 
refined the search above by adding “AND (Africa)”. We found 
424 hits and reviewed them all, citing only those specifically 
relevant to the discussion of research participant remuneration.
We produced a summary document to define the appropriate 
contexts in which remuneration might occur and then framed the 
parameters for a Malawi remuneration table. We discussed in 
detail the need for transparent guidelines such that researchers 
could use a framework, and regulators could evaluate the 
rationale underpinning researcher protocols for remuneration3.
Malawi remuneration table development
Using the acceptable parameters obtained from the literature 
review, we determined a range of values for each parameter and 
then developed tables of values for each parameter. We then 
determined, in a public discussion, if these value estimates 
seemed reasonable to a participant group of researchers and 
regulators. Finally, we stated current exchange rates to allow 
comparison in other settings and after exchange rate changes. 
In this way, we produced a table that can be used by researchers 
and regulators alike to determine appropriate remuneration 
values.
Results and discussion
Literature review
The development of current international practice. In 1998, 
research participant remuneration in the USA was shown to 
be inconsistent between different sites in multi-site studies, 
between studies at the same site and between procedures in 
the same study4. This inconsistency was caused by anxiety 
about inducement and a lack of written guidelines for 
researchers and Research Ethics Committees (REC; also known 
as Institutional Review Boards (IRB), but REC will be used in 
this paper). Several studies indicated, however, that researchers 
were generally in favour of reimbursement both in clinical 
trials5 and in the social sciences6. The fact that remuneration 
might bias increased recruitment from impoverished sub-
jects was considered less of a problem than alternatives such 
as no remuneration, compulsory participation or means-tested 
remuneration7. Furthermore, studies indicate that payments 
did not cause volunteers to ignore risk8, and that remunerated 
research participants considered a complex variety of factors 
before participation9,10. Phase 1 trial participants, for example, 
were less likely to participate in trials of psychotropic drugs 
than other drug studies, and in trials with painful biopsy 
sampling compared to those with no pain involved11. Further, 
adolescent patients made good judgments, tending to be altru-
istic compared to their parents12. A study attempting to increase 
elderly patient participation in research showed that financial 
remuneration had little effect13. Motivating factors reported 
by research participants often include community benefit, the 
advancement of science, personal interest and seeking addi-
tional health professional contact14–16. A Viewpoint paper in the 
Lancet in 2005 concurred that good regulator boards (REC) 
were critical in determining risk benefit ratio in research, and 
were more important in ensuring ethical research than the 
nature or scale of participant benefits2. In modern day practice, 
the offer of payments to participate in studies causing harm (a 
definition of “coercion”) has been outlawed by the appropriate 
processes of REC17.
A 2018 framework to guide the ethical payment of research 
participants published in the New England Journal of Medicine1, 
consistent with CIOMS guidelines3, distinguished three rationales 
for remuneration which were:
•     reimbursement of out-of-pocket expenses such as travel 
expenses,
•     compensation for time lost at a rate approximately equal to 
unskilled labour, and
•     some incentive to participation, calculated to improve the 
likelihood of study recruitment and completion1.
Current practice is therefore that a minimum reimbursement 
is almost always expected, calculated as reimbursement for 
expenses and compensation for time lost. The same guideline 
indicates that research participant remuneration should be pro-
rated (paid per activity and not dependent on study comple-
tion), and clearly documented in both the REC protocol and 
patient information sheet. Recent detailed enquiry among 
investigators and REC Chairs in the USA, however, showed 
that only 19% of protocols included time-based compensation 
and only 12% of protocols included procedure-based estimation 
of burden18. Incentives in the form of study completion bonus 
(9% of protocols) or increased attendance allowance (10% of 
protocols) were seldom recorded. There was, however, good 
documentation of remuneration in the patient information 
sheet (94% of protocols) and this was usually prorated 
(73% protocols). Problems still remain, however, as early career 
researchers particularly struggle to define appropriate patient 
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involvement in research19, and there is some evidence that 
payments are not adequate in some studies20. We therefore 
concluded that transparent guidelines would be useful and 
applicable in Malawi, where the economic context of a low- or 
middle-income country (LMIC) drives particular concern about 
remuneration in research.
The development of guidelines for remuneration in Africa. The 
underlying principles for remuneration in LMIC are identical to 
those elsewhere, but there are contextual considerations includ-
ing culture that must be included in planning remuneration21, 
and a relative lack of literature to guide researchers. A recent 
review has concluded that there is an urgent need for basic 
descriptive work in India (Marathe, 2018) but the KEMRI 
Wellcome group in Kenya have worked for several years to define 
types of volunteer remuneration and good ethical practice in 
Africa22,23. The KEMRI group have particularly pointed out 
that individual remuneration, including that offered to patients, 
is best served by financial compensation, but community rec-
ognition is best achieved with in-kind contributions to health 
facilities and community projects23. Further, researchers should 
be award of the potential for remuneration to produce family 
discord. There is a need for transparency in patient information 
sheets24 and in actual practice25 but nevertheless, guidelines can 
be developed in complex situations, including among patients 
with malnutrition26, and among people living with HIV/AIDS 
(PLWHA). Among PLWHA, research participant remuneration 
has even been shown to increase patient’s well-being and 
self-worth27 to the point where remuneration post-trial has been 
considered28. It has been proposed that participant remuneration 
results in both individual and community good29, and indeed 
that defining the remuneration only in terms of opportunity cost, 
matched to work, is to reduce the opportunity for community 
good.
In 2002 in South Africa, flat rates for research participation were 
suggested by the Medical Control Council but did not meet with 
community approval30,31. The South African NHREC (2012) 
guidelines for “Payment of Trial Participants in South Africa: 
Ethical Considerations for REC” note that a recommendation 
for a flat rate was made at a time when NHREC was not for-
mally constituted, and the guidelines suggest that participants 
should be compensated for time, inconvenience and expenses32. 
A recent Malawi recommendation of minimum rates for 
reimbursement when subjects attend facilities for research 
led to some confusion among researchers and REC, requiring 
discussion to understand the nuance and exceptions stated in 
the recommendation. In a study where the actual amount of 
reimbursement was discussed in Kenya, zero payments were 
determined to be unfair, and high reimbursement evoked 
suspicion (“what do they want if they are paying so much?”). 
Appropriate payment was related to the basic minimum wage 
($3.50 per day) and to the amount a person might earn in the 
market selling goods ($80-300)16. In a study of prospective 
participants in research bronchoscopy in Malawi, Focus Group 
Discussion confirmed that remuneration for travel, food and 
lost earnings would be sufficient33 and follow-up with these 
authors confirms that Focus Group Discussion participants did 
in fact attend for multiple bronchoscopies.
In conclusion, therefore, there are both general guidelines and 
examples of good practice internationally and in Africa. We 
could not find examples of specific guidance for researchers 
and regulators. Whilst investigators may be using appropriate 
formulae to determine research participant payments, they 
typically do not include the calculation in protocols submitted 
to REC wherever this has been audited. Review committees 
are therefore not able to make judgments on the compensa-
tion offered to research participants based on any consistent 
guideline20. The situation in Malawi could be immediately 
improved by reference to current good practice and by publica-
tion of a specific guideline.
Current practice and development of tables for Malawi 
research studies
There is a long tradition of both community- and hospital-
based research in Malawi, and remuneration has been used 
in each of the three categories discussed above. As in other 
regions, financial remuneration is not the key motivational 
factor underpinning research participants involvement decisions 
in Malawi14 and Kenya23—considerations of access to health 
care, examination and tests are equally if not more important33.
Reimbursement of expenses. Travel expenses, including those 
of a travelling companion, with food and accommodation costs 
are often paid to research subjects in Malawi14. Where transport 
is difficult, a vehicle is provided as an alternative and is 
appreciated33. Telephone prepaid charge units are provided 
to study subjects or to community liaison volunteers when 
information is needed in surveillance studies34.
Current advice is that actual travel and subsistence expenses 
should be reimbursed in studies but the practical means to do 
this is clumsy as receipts are often not issued and the admin-
istrative duty to make specific payments are often delegated to 
clinic staff. Further, ad hominem payments do not provide a 
basis for planning grant budgets and so the Malawi tables are 
constructed using reasonable predictive data. Travel was deter-
mined in three bands of <5 km, 5–10 km, and 10–15 km using 
standard minibus fares, but we recommend that a single rate be 
paid in any one study based on the radius of recruitment. At the 
workshop, participants contributed examples in region where 
variable travel reimbursement has led to confusion and frustra-
tion in the community from whom participants are recruited 
therefore this was noted and a recommendation included in 
the resulting table (Table 1). Food was calculated using street 
restaurant food costs for mid-day meals and accommodation 
at rates charged by lodges with walled secure compounds. 
Overnight accommodation is very unusual in research studies, 
as is travel of more than 15 km.
Compensation for time and burden. Particularly in healthy 
volunteer studies involving a procedure, compensation for both 
time and the burden of the study are paid. In the Malawi tables, 
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Table 1. The Malawi research remuneration table.
MALAWI RESEARCH 
PARTICIPANT 
REMUNERATION
Reimburse Expenses Rate in MK Number of events Total 
a) Transport - see Note A 
b) Subsistence (one meal) 1500
c) Accommodation (one night) 15000
Compensation 
a) Time - see Note B 
Total time in hours travelling
Total time in hours at facility
Time in days (day = 8hrs) 1000
b) Burden - see Note C 
Procedure A 2000
Procedure B 6000
Procedure C 10000
TOTAL for study - see Note D 
AVERAGE per visit*
Note A: Transport rates. Use the same for all participants in the study, based on furthest 
travel (5km = 300MK; 10km = 600MK; 15km = 900MK). Note B: Time. Use total time 
including travel, waiting, consultation, tests, waiting for results and treatment.  
Note C: Burden Categories. (A) mild discomfort: venesection <60ml, lung function 
testing, Xray = 2000MK. (B) Moderate discomfort: venesection >60ml, bone marrow, 
lumbar puncture = 6000MK. [C] Long or complex: bronchoscopy or GI endoscopy and 
biopsy/BAL = 10000MK. Note D: Minimum remuneration. Recommendation is that this 
should not be less than 7000 for studies attending facilities. *Divide Total by transport 
events (C3) to determine Average per visit (MK exchange rate at the time of writing  
960 MK to 1 GBP; 700 MK to 1 USD).
the opportunity cost sustained by a volunteer has been calcu-
lated using the total time incurred in the study, to include travel 
to-and-from, waiting at the facility, direct involvement in the 
project and any time delayed after the process. Time used in 
completing follow-up diaries or on follow-up phone calls was 
also included. Time may be reimbursed as a time equivalent in 
minimum wage labour, but this may under-report the opportu-
nity cost16,30. We consider that the minimum wage provides a 
reasonable remuneration provided that time is adequately 
evaluated7. In the case of patients receiving a treatment or 
diagnostic test of proven value that might be outside the normal 
service, this would not constitute a burden.
The burden of participations in a study, including discom-
fort, anxiety or embarrassment was included in three bands of 
procedure discomfort. Risk per se should be minimised by study 
design and was not specifically reimbursed (this constitutes 
coercion); we took the view that any harm sustained should be 
covered by insurance and not participant remuneration. There 
are examples of good practice regarding research participant’s 
discomfort burden in Malawi. For example, for bronchoscopy 
studies, a consultative exercise including participants, research 
team and health care providers determined participant remu-
neration. Subsequently, participant interviews determined that 
most participants were content with the remuneration offered, 
and that the remuneration was not the reason for participation15. 
In Kenya, reasons for participation included improve medical 
care, as published elsewhere14. In a study requiring residential 
monitoring, participants cited saving for various projects (business, 
housing, school-fees) as a motivation to participate, and lack of 
family support as a disincentive16.
Incentives to participation. In Malawi, there is currently no 
equivalent of The Over-volunteering Prevention System (TOPS) 
found in other centres35. Studies must therefore screen carefully 
and avoid the problem of over-recruitment by participant 
enquiry. One survey of nasopharyngeal carriage, offering a 
bottle of Coca-Cola as remuneration, observed a problem of 
over-recruitment (volunteers attempting to participate twice) 
and had to re-structure consent and sampling processes36. 
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Given that a risk of over-volunteering therefore already exists 
in Malawi, and that there is no surveillance system in place, 
caution is advised on offering incentives to participation.
In the tables, we noted that remuneration of participants should 
be pro-rated (in the sense of pro rata, in that completion is not 
necessary) because of fairness needed when participants are 
required to withdraw from a study (e.g. owing to side effects 
in a drug trial). Participants might fail to disclose adverse 
side effects if this would sustain a reimbursement penalty. Com-
pletion bonuses run a risk of participant coercion. Increased 
payments for repeat procedures that become tedious and 
burdensome were discussed at an option but there was no 
consensus of support for this approach.
Malawi remuneration tables
In order that the challenge of presenting clear, specific 
guidelines that would allow transparency in reviewing proto-
cols at REC, the Malawi research remuneration tables were 
developed as shown in Table 1 and Table 2. Table 1 shows the 
table for calculation, with Table 2 completed for a simple study 
and Table 3 for a more complex study. Some degree of interna-
tional comparison may be achieved using the dollar exchange 
rate provided. This does not, however, take any account of 
purchasing power or local wages therefore appropriate regional 
and international comparison will be made by replacing the 
values for round-trip travel (5, 10 and 15km) and for a day’s 
wages at the local minimum wage. A working example of the 
remuneration Table is given in Supplementary File 1.
Conclusion
International guidelines and current best practice both indicate 
that structured remuneration of research participants is ethical 
and appropriate in Malawi. From a review of the literature, 
we provide an underpinning rationale for remuneration based 
on reimbursement of expenses and compensation for time 
and burden, but not incentive to participate. We then provide 
specific tables to guide researchers and regulators in the amount 
Table 2. Worked example for a simple study. Volunteers attend for 
collection of a complex data set in which the process of travel and study 
completion takes 4 hours including a blood test. They re-attend for results 
on a second occasion taking one hour. This example using the Malawi 
table shows the remuneration for a participant who travelled 15km round 
trip (900MK), was provided lunch (1500MK) in a day that involved  
6 hours of attendance and one large blood sample and was then followed 
up on a second visit which only required 2 hrs time in travel and at the 
facility (hence 8 hours total) and a small blood sample. Remuneration was 
MK12800. The US dollar exchange rate was 719 MK to the dollar.
MALAWI RESEARCH 
PARTICIPANT 
REMUNERATION
Reimburse Expenses Rate in MK Number of events Total 
a) Transport - see Note A 900 2 1800
b) Subsistence (one meal) 1500 1 1500
c) Accommodation (one night) 15000 0 0
Compensation 
a) Time - see Note B
Total time in hours travelling 4
Total time in hours at facility 8
Time in days (day = 8hrs) 1000 1.5 1500
b) Burden - see Note C 0
Procedure A 2000 1 2000
Procedure B 6000 1 6000
Procedure C 10000 0 0
TOTAL for study- see Note D 12800 
AVERAGE per visit* 6400
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Table 3. Worked example for a complex study. Volunteers attend for 
collection of a complex data set 4 hours and a large blood test. They re-
attend 6 further occasions taking one hour and a simple blood test each 
time. There are 2 additional visits for bronchoscopy (4 hours). This example 
shows the participant travelled 15km round trip, attended for 4 hrs and 
had a large blood test, then 6 follow-up visits and 2 visits for bronchoscopy 
resulting in a total study remuneration of MK 55100.
MALAWI RESEARCH 
PARTICIPANT 
REMUNERATION
Reimburse Expenses Rate in MK Number of events Total 
a) Transport - see Note A 900 9 8100
b) Subsistence (one meal) 1500 3 4500
c) Accommodation (one night) 15000 0 0
Compensation 
a) Time - see Note B
Total time in hours travelling 18
Total time in hours at facility 18
Time in days (day = 8hrs) 1000 4.5 4500
b) Burden - see Note C 0
Procedure A 2000 6 12000
Procedure B 6000 1 6000
Procedure C 10000 2 20000
TOTAL for study- see Note D 55100 
AVERAGE per visit* 6122
to remunerate. We publish these in Wellcome Open Research 
in order that revised versions can be updated and available as 
required.
Data availability
All data underlying the results are available as part of the article 
and no additional source data are required.
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